• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Pacific Biosciences of California Inc.

    11/14/24 5:48:11 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $PACB alert in real time by email
    SC 13G/A 1 tm2427620d17_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

    Pacific Biosciences of California, Inc.

    (Name of Issuer)

     

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

     

    69404D108

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

     

    xRule 13d-1(c)

     

    ¨Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Madrone Opportunity Fund, L.P.

    2. Check the Appropriate Box if a Member of a Group (see instructions)
      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    23,391,915 Shares (2)

    6.

    Shared Voting Power

    0 Shares

    7.

    Sole Dispositive Power

    23,391,915 Shares (2)

    8.

    Shared Dispositive Power

    0 Shares

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    23,391,915 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    8.6% (3)

    12.

    Type of Reporting Person (see instructions)

    PN

     

    (1)This Schedule 13G is filed by Madrone Opportunity Fund, L.P. (“Madrone”), Madrone Capital Partners, LLC (“Madrone GP”), Shimoda Holdings, LLC (“Shimoda”), Greg Penner (“Penner”), Jameson McJunkin (“McJunkin”) and Thomas Patterson (“Patterson” and, together with the Madrone, Madrone GP, Shimoda, Penner and McJunkin, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)The shares are held by Madrone. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

      

    Page 2 of 10 pages

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Madrone Capital Partners, LLC

    2.

    Check the Appropriate Box if a Member of a Group (see instructions) 

      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    0 Shares

    6.

    Shared Voting Power

    23,391,915 Shares (2)

    7.

    Sole Dispositive Power

    0 Shares

    8.

    Shared Dispositive Power

    23,391,915 Shares (2)

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    23,391,915 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    8.6% (3)

    12.

    Type of Reporting Person (see instructions)

    OO

     

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)The shares are held by Madrone. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

     

    Page 3 of 10 pages

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Shimoda Holdings, LLC

    2.

    Check the Appropriate Box if a Member of a Group (see instructions) 

      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    0 Shares

    6.

    Shared Voting Power

    3,500,000 Shares (2)

    7.

    Sole Dispositive Power

    0 Shares

    8.

    Shared Dispositive Power

    3,500,000 Shares (2)

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    3,500,000 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    1.3% (3)

    12.

    Type of Reporting Person (see instructions)

    OO

     

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)The shares are held by Shimoda. Penner is a Vice President and Manager of Shimoda and shares voting and dispositive power over the shares held by Shimoda.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

     

    Page 4 of 10 pages

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Greg Penner

    2.

    Check the Appropriate Box if a Member of a Group (see instructions) 

      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    United States

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    0 Shares

    6.

    Shared Voting Power

    26,891,915 Shares (2)

    7.

    Sole Dispositive Power

    0 Shares

    8.

    Shared Dispositive Power

    26,891,915 Shares (2)

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    26,891,915 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    9.9% (3)

    12.

    Type of Reporting Person (see instructions)

    IN

     

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)Includes (i) 23,391,915 shares held by Madrone and (ii) 3,500,000 shares held by Shimoda. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone. Penner is a Vice President and Manager of Shimoda and shares voting and dispositive power over the shares held by Shimoda.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

      

    Page 5 of 10 pages

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Jameson McJunkin

    2.

    Check the Appropriate Box if a Member of a Group (see instructions)

      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    United States

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    0 Shares

    6.

    Shared Voting Power

    23,391,915 Shares (2)

    7.

    Sole Dispositive Power

    0 Shares

    8.

    Shared Dispositive Power

    23,391,915 Shares (2)

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    23,391,915 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    8.6% (3)

    12.

    Type of Reporting Person (see instructions)

    IN

     

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)The shares are held by Madrone. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

      

    Page 6 of 10 pages

     

     

    CUSIP No.   69404D108

    1.

    Names of Reporting Persons

    Thomas Patterson

    2.

    Check the Appropriate Box if a Member of a Group (see instructions)

      (a)
      (b) x (1)
    3.

    SEC USE ONLY

     

    4.

    Citizenship or Place of Organization

    United States

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person With:

    5.

    Sole Voting Power

    0 Shares

    6.

    Shared Voting Power

    23,391,915 Shares (2)

    7.

    Sole Dispositive Power

    0 Shares

    8.

    Shared Dispositive Power

    23,391,915 Shares (2)

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    23,391,915 Shares (2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

     

    ¨
    11.

    Percent of Class Represented by Amount in Row 9

    8.6% (3)

    12.

    Type of Reporting Person (see instructions)

    IN

     

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)The shares are held by Madrone. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone.

     

    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

     

    Page 7 of 10 pages

     

     

    Item 1(a).

    Name of Issuer:

     

    Pacific Biosciences of California, Inc.

       
    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

     

    1305 O’Brien Drive, Menlo Park, CA 94025

       
    Item 2(a).

    Name of Person Filing:

     

    Madrone Opportunity Fund, L.P. (“Madrone”)
    Madrone Capital Partners, LLC (“Madrone GP”)
    Shimoda Holdings, LLC (“Shimoda”)
    Greg Penner (“Penner”)
    Jameson McJunkin (“McJunkin”)
    Thomas Patterson (“Patterson”)

       
    Item 2(b).

    Address of Principal Business Office or, if none, Residence:

     

    1149 Chestnut Street, Suite 200, Menlo Park, CA 94025

       
    Item 2(c).

    Citizenship:

     

    All entities were organized in Delaware

    All individuals are United States Citizens

       
    Item 2(d).

    Title of Class of Securities:

     

    Common Stock

       
    Item 2(e).

    CUSIP Number:

     

    69404D108

       
    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

       
    Item 4. Ownership
       
      The following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 is provided as of November 14, 2024:

     

    Fund Entities  Shares Held
    Directly
       Sole
    Voting
    Power
       Shared Voting Power   Sole
    Dispositive
    Power
       Shared
    Dispositive
    Power
       Beneficial
    Ownership
       Percentage
    of Class (3)
     
    Madrone (1)   23,391,915    0    23,391,915    0    23,391,915    23,391,915    8.6%
    Madrone GP (1)   0    0    23,391,915    0    23,391,915    23,391,915    8.6%
    Shimoda (2)   3,500,000    0    3,500,000    0    3,500,000    3,500,000    1.3%
    Penner (1) (2)   0    0    26,891,915    0    26,891,915    26,891,915    9.9%
    McJunkin (1)   0    0    23,391,915    0    23,391,915    23,391,915    8.6%
    Patterson (1)   0    0    23,391,915    0    23,391,915    23,391,915    8.6%

     

    (1)Includes 23,391,915 shares held by Madrone. Madrone GP is the general partner of Madrone. Penner, McJunkin and Patterson are managers of Madrone GP and share voting and dispositive power over the shares held by Madrone.
    (2)Includes 3,500,000 shares held by Shimoda. Penner is a Vice President and Manager of Shimoda and shares voting and dispositive power over the shares held by Shimoda.
    (3)This percentage is calculated based on 272,528,950 shares of the Issuer’s stock outstanding as of July 31, 2024, as set forth in the Issuer’s Quarterly Reporting on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 9, 2024.

     

    Page 8 of 10 pages

     

      

    Item 5. Ownership of Five Percent or Less of a Class
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ¨
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
       
      Not applicable
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
       
      Not applicable
       
    Item 8. Identification and Classification of Members of the Group
       
      Not applicable
       
    Item 9. Notice of Dissolution of Group
       
      Not applicable
       
    Item 10. Certification
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

     

    Page 9 of 10 pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2024

     

    Madrone Opportunity Fund, L.P.  
       
    By: Madrone Capital Partners, LLC  
    Its   General Partner  
       
    By: /s/ Greg Penner  
      Name: Greg Penner  
      Title: Manager  
       
    Madrone Capital Partners, LLC  
       
    By: /s/ Greg Penner  
      Name: Greg Penner  
      Title: Manager  
       
    Shimoda Holdings, LLC  
       
    By: /s/ Greg Penner  
      Name: Greg Penner  
      Title: Vice President and Manager  
       
    /s/ Greg Penner  
    Greg Penner  
       
    /s/ Thomas Patterson  
    Thomas Patterson  
       
    /s/ Jameson McJunkin  
    Jameson McJunkin  

     

    Page 10 of 10 pages

     

    Get the next $PACB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PACB

    DatePrice TargetRatingAnalyst
    11/11/2024Buy → Neutral
    UBS
    6/3/2024$4.00Buy
    Jefferies
    4/22/2024Overweight → Neutral
    JP Morgan
    4/18/2024$7.00 → $2.50Buy → Neutral
    Goldman
    12/14/2023$11.00Overweight
    Stephens
    12/14/2023Neutral
    Guggenheim
    12/13/2023Peer Perform
    Wolfe Research
    11/17/2023$13.00 → $10.00Neutral → Buy
    UBS
    More analyst ratings